CME Group Inc (NASDAQ:CME) Shares Sold by Creative Planning

Creative Planning reduced its position in shares of CME Group Inc (NASDAQ:CME) by 7.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,208 shares of the financial services provider’s stock after selling 1,862 shares during the period. Creative Planning’s holdings in CME Group were worth $4,905,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of CME. Buckingham Asset Management LLC lifted its stake in CME Group by 1.4% in the 2nd quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock worth $700,000 after acquiring an additional 49 shares in the last quarter. IHT Wealth Management LLC lifted its stake in CME Group by 1.1% in the 2nd quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock worth $855,000 after acquiring an additional 50 shares in the last quarter. Pitcairn Co. lifted its stake in CME Group by 2.3% in the 2nd quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock worth $435,000 after acquiring an additional 51 shares in the last quarter. Lourd Capital LLC lifted its stake in CME Group by 3.5% in the 2nd quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock worth $314,000 after acquiring an additional 55 shares in the last quarter. Finally, Garner Asset Management Corp lifted its stake in CME Group by 1.1% in the 2nd quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock worth $1,009,000 after acquiring an additional 55 shares in the last quarter. 84.80% of the stock is currently owned by institutional investors and hedge funds.

CME stock traded up $0.01 during mid-day trading on Friday, hitting $199.01. The stock had a trading volume of 35,728 shares, compared to its average volume of 1,334,346. The company has a current ratio of 1.04, a quick ratio of 1.05 and a debt-to-equity ratio of 0.14. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91. The company has a fifty day moving average of $208.72 and a 200 day moving average of $201.48. The stock has a market capitalization of $70.53 billion, a price-to-earnings ratio of 29.12, a PEG ratio of 3.86 and a beta of 0.18.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.15. CME Group had a return on equity of 9.54% and a net margin of 40.93%. The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same period in the prior year, the firm posted $1.45 EPS. The business’s revenue was up 41.3% compared to the same quarter last year. As a group, sell-side analysts expect that CME Group Inc will post 6.91 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Tuesday, December 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. CME Group’s dividend payout ratio is 43.99%.

Several equities research analysts recently issued reports on CME shares. UBS Group reduced their price objective on CME Group from $220.00 to $218.00 and set a “neutral” rating for the company in a research note on Thursday, October 31st. Citigroup increased their price objective on CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. Wells Fargo & Co increased their price objective on CME Group from $200.00 to $205.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Deutsche Bank increased their price objective on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Finally, Berenberg Bank downgraded CME Group from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $236.00 to $227.00 in a research note on Thursday, September 19th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. CME Group presently has an average rating of “Hold” and an average price target of $203.36.

In other news, insider Sean Tully sold 7,200 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the transaction, the insider now owns 19,923 shares of the company’s stock, valued at approximately $4,445,418.99. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $217.62, for a total value of $544,050.00. Following the transaction, the chief financial officer now directly owns 30,354 shares in the company, valued at approximately $6,605,637.48. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,636 shares of company stock worth $3,001,008. 1.20% of the stock is currently owned by insiders.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Basic Economics creates winners and losers

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply